Loading page…
Glycorex Transplantation AB Sustainability Reports
Glycorex Transplantation AB is a medical technology company that develops, manufactures, and markets innovative medical devices for organ transplantation. Its core technology platform includes products like Glycosorb ABO, which enables organ transplants across blood group barriers by selectively removing specific blood antibodies.
Sector: Professional & technical services
Country: Sweden
Exchange: Nordic Growth Market
LEI: 549300BFHBYZ3X96EP25
FIGI: BBG001SDN315
12 reports from 2009 to 2025